TransMedics Group, Inc.
70.74USD
-1.3200 (-1.83%)
Not enough data yet
A reading needs 5 members, each at least 14 days old with a track record on this site (simulated portfolios and calls), who shared a take in the last 30 days; 2 of them need a strong record.
Sign in to share your take on TMDX.
Consensus EPS on the street’s adjusted basis, not the filed GAAP figure — which is why the actuals here can differ from the income statement.
| Period | Consensus EPS | 90 days ago | Revisions up (30d) | Revisions down (30d) |
|---|---|---|---|---|
| Current quarter | $0.29▼ | $0.39 | 0 | 2 |
| Next quarter | $0.5▼ | $0.6 | 0 | 2 |
| Current year | $1.51▼ | $1.76 | 0 | 3 |
| Next year | $2.25▼ | $2.86 | 0 | 2 |
Beat in 2 of the last 4
| Quarter | Estimate | Actual | Surprise |
|---|---|---|---|
| 2026-06-30 | $0.48 | $0.44 | -0.04 (-7.4%) |
| 2026-03-31 | $0.61 | $0.3 | -0.31 (-50.9%) |
| 2025-12-31 | $0.37 | $0.53 | +0.15 (+41.0%) |
| 2025-09-30 | $0.36 | $0.66 | +0.30 (+83.3%) |
127 ratings from 16 firms
Ratings are attributed to the research firm, not to individual analysts. See every ticker.
| Firm | Action | Rating | Price Target | Date |
|---|---|---|---|---|
| Canaccord Genuity | Maintained | Buy | $95 $94 | Oct 13, 2026 |
| Barclays | Initiated | Overweight | $120 | Oct 7, 2026 |
| TD Cowen | Reiterated | Buy | $120 | Sep 8, 2026 |
| UBS | Maintained | Neutral | $80 $77 | Aug 5, 2026 |
| Piper Sandler | Reiterated | Overweight | $120 $100 | Aug 5, 2026 |
| Needham | Maintained | Buy | $142 $106 | Aug 3, 2026 |
| UBS | Initiated | Neutral | $80 | Jul 28, 2026 |
| Evercore ISI Group | Maintained | Outperform | $100 $90 | Jul 6, 2026 |
| TD Cowen | Reiterated | Buy | $120 | Jul 1, 2026 |
| Canaccord Genuity | Maintained | Buy | $124 | Jun 30, 2026 |
| Stifel | Maintained | Hold | $75 $80 | Jun 18, 2026 |
| Stifel | Maintained | Hold | $85 $75 | May 26, 2026 |
| Canaccord Genuity | Maintained | Buy | $152 $124 | May 6, 2026 |
| TD Cowen | Maintained | Buy | $190 $120 | May 6, 2026 |
| Stifel | Maintained | Hold | $130 $85 | May 6, 2026 |
| Piper Sandler | Maintained | Overweight | $160 $120 | May 6, 2026 |
| Needham | Maintained | Buy | $174 $142 | May 6, 2026 |
| Evercore ISI Group | Maintained | Outperform | $170 $118 | Apr 6, 2026 |
| Stifel | Maintained | Hold | $115 $130 | Mar 9, 2026 |
| JP Morgan | Maintained | Neutral | $114 $149 | Feb 25, 2026 |
| Oppenheimer | Maintained | Outperform | $150 $175 | Feb 25, 2026 |
| Piper Sandler | Maintained | Overweight | $140 $160 | Feb 25, 2026 |
| Evercore ISI Group | Maintained | Outperform | $155 $170 | Feb 25, 2026 |
| Needham | Maintained | Buy | $166 $174 | Feb 25, 2026 |
| Canaccord Genuity | Maintained | Buy | $147 $148 | Dec 17, 2025 |
71 filings from 15 insiders · 14 buy / 1 sell over 6m
Officers and directors of TMDX, from the last two years of filings. Grants, gifts and option exercises are shown but not colour-coded — they are compensation, not a view on the price.
| Insider | Action | Shares | Price | Value | Date |
|---|---|---|---|---|---|
| Weill DavidDirector | Buy | 1.3k | $81.63 | $109k | Sep 11, 2026 |
| TOBIN JAMES RDirector | Giftindirect | 18.0k | — | — | Aug 17, 2026 |
| HASSANEIN WALEED HChief Executive Officer | Grant | 49.7k | — | — | Jul 10, 2026 |
| CORCORAN NICHOLASOfficer | Grant | 11.7k | — | — | Jul 10, 2026 |
| HERNANDEZ GERARDOChief Financial Officer | Grant | 17.2k | — | — | Jul 10, 2026 |
| GUNDERSON THOMAS JAMESDirector | Sell | 9.6k | $75.06 | $722k | Jun 15, 2026 |
| GUNDERSON THOMAS JAMESDirector | Exercise | 19.3k | $2.21 | $43k | Jun 15, 2026 |
| KANIA EDWIN M JRDirector | Grant | 2.9k | — | — | May 20, 2026 |
| TOBIN JAMES RDirector | Grant | 2.9k | — | — | May 20, 2026 |
| RAINES MERILEEDirector | Grant | 2.9k | — | — | May 20, 2026 |
| GUNDERSON THOMAS JAMESDirector | Grant | 2.9k | — | — | May 20, 2026 |
| LOVELL STEPHANIEDirector | Grant | 2.9k | — | — | May 20, 2026 |
| BASILE EDWARD M.Director | Grant | 2.9k | — | — | May 20, 2026 |
| WEILL DAVIDDirector | Grant | 2.9k | — | — | May 20, 2026 |
| FORSYTH MATTHEW SGeneral Counsel | Grant | 15.4k | — | — | May 19, 2026 |
| LOVELL STEPHANIEDirector | Sell | 1.2k | $149.62 | $178k | Mar 4, 2026 |
| HERNANDEZ GERARDOChief Financial Officer | Sell | 7.6k | $139.12 | $1.12M | Mar 4, 2026 |
| WEILL DAVIDDirector | Sell | 3.6k | $146.82 | $524k | Mar 4, 2026 |
| WEILL DAVIDDirector | Exercise | 3.6k | $14.20 | $51k | Mar 4, 2026 |
| HERNANDEZ GERARDOChief Financial Officer | Exercise | 7.2k | $69.84 | $515k | Mar 4, 2026 |
No analyst notes on TMDX yet.
Members whose judged calls on TMDX have played out most reliably.
No settled calls on TMDX yet. Nobody has filed a call with a deadline on it.
A member is listed once they have three judged calls on a name.
A call with a target is judged on whether the price reaches it by the deadline, counting each day's high (a buy) or low (a sell) from the day after the call was made. A call without one is judged on whether the price at the close on the deadline is higher (a buy) or lower (a sell) than the price the call was made at: the live price when it was saved, for a call made with Make a call, or the last close before the day it was filed, for a call made in a note. Not against the market or an index.
A percentage appears once five calls have reached their deadline. A target reached sooner is shown as played out early, and counts toward the percentage when its deadline passes, because a miss cannot be known before then.
A member’s prediction, judged on price history · not investment advice
Analyst Ratings
11 analysts covering
| Period | Strong Buy | Buy | Hold | Sell | Strong Sell | Consensus |
|---|---|---|---|---|---|---|
| Current | 3 | 6 | 4 | 0 | 0 | Buy2.08 |
| 1 mo ago | 2 | 6 | 4 | 0 | 0 | Buy2.17 |
| 2 mo ago | 2 | 6 | 4 | 0 | 0 | Buy2.17 |
| 3 mo ago | 2 | 6 | 4 | 0 | 0 | Buy2.17 |